CCL19, also termed Macrophage Inflammatory Protein-3β (MIP-3β), is a CC chemokine that binds to the CCR7 receptor, facilitating immune cell trafficking to lymphoid tissues . It is critical for:
Lymphocyte Migration: Recruitment of naïve T cells, dendritic cells, and B cells to secondary lymphoid organs .
Tumor Microenvironment Modulation: High CCL19 expression correlates with improved prognosis in cancers like breast and ovarian cancer, linked to enhanced CD8+ T cell infiltration .
Autoimmune Regulation: Mediates inflammatory responses in rheumatoid arthritis and graft-versus-host disease .
Cancer Biomarker: Elevated CCL19 in tumor microenvironments predicts favorable outcomes in breast cancer (HR = 0.62, p < 0.05) .
Inflammatory Diseases: Detects CCL19 overexpression in rheumatoid arthritis synovium .
Immunotherapy Enhancement: CCL19 agonists are explored to boost CD8+ T cell recruitment in solid tumors .
Autoimmune Disease Targets: Neutralizing antibodies inhibit CCR7-mediated inflammation in Crohn’s disease models .
Receptor Internalization: CCL19 binding induces CCR7 desensitization, unlike CCL21 .
Viral Mimicry: Epstein-Barr virus upregulates CCR7 in infected B cells, exploiting CCL19/CCL21 signaling .
CCL19 vs. CCL21 Specificity: Structural determinants of CCR7 binding remain under investigation .
Biomarker Validation: Prospective trials are needed to confirm CCL19 as a pan-cancer immunotherapy biomarker .
Note: If "CML19" refers to a novel or obscure target, additional clarification or updated nomenclature may be required.
Method: Use a combination of Western blotting (against Arabidopsis lysates) and competitive ELISA with recombinant CML19 and homologs (e.g., CML8 or CML24). Include calcium chelators (e.g., EGTA) to confirm Ca²⁺-dependent binding profiles .
Example data:
| Technique | Target | Signal Reduction with EGTA | Cross-reactivity |
|---|---|---|---|
| Western | CML19 | 85% | <5% (CML8/CML24) |
| ELISA | CML19 | 92% | <3% (CML8/CML24) |
Method:
Co-immunoprecipitation (Co-IP): Use Arabidopsis root nuclear extracts with anti-CML19 antibodies, followed by mass spectrometry to identify SAC3B .
Isothermal Titration Calorimetry (ITC): Quantify binding thermodynamics between recombinant CML19 and SAC3B-derived peptides (e.g., SAC3Bp) .
Circular Dichroism (CD): Monitor conformational changes in CML19 upon Ca²⁺ binding .
Method:
Key finding: SAC3Bp binds apo-CML19 with Kd = 1.2 µM and Ca²⁺-CML19 with Kd = 0.3 µM, indicating dual binding modes .
Method:
Method:
Yield improvement:
| Condition | Yield (mg/L) | Monomer Content |
|---|---|---|
| Standard | 2.5 | 60% |
| Optimized | 18.7 | 92% |
For structural studies: Combine NMR spectroscopy (e.g., ¹H-¹⁵N HSQC) with X-ray crystallography to resolve Ca²⁺-induced conformational shifts .
For cellular localization: Employ Arabidopsis lines expressing CML19-GFP under native promoters, coupled with confocal microscopy .
Data contradiction resolution: Use orthogonal techniques (e.g., ITC + SPR) to validate binding parameters and mitigate assay-specific artifacts .